RxDoctor Payments Data

Andrew Berg

Physician Assistant · Lees Summit, MONPI 1548383789

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $178,236 of the $244,766 with a category attached, or 72.8%. 36 manufacturers reported payments, led by Johnson & Johnson at 26.1% of the total. 2025 is the largest year on record at $89,190, 4.3 times the $20,528 reported in 2021. Among physician assistant clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$244,766in general payments, 2019–2025

Across 1,417 payments — averaging $172.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$64K
  • UCB, Inc.$60K
  • Sanofi$35K
  • Regeneron Healthcare Solutions, Inc.$28K
  • Janssen Scientific Affairs, LLC$24K
  • Galderma Laboratories, L.p.$5K
  • plus $28K from 30 others

What the payments were for

  • Consulting fees$15,0726%
  • Speaking & faculty fees$178,23673%
  • Travel & lodging$20,2258%
  • Food & beverage$30,82913%
  • Education$3800%
  • Gifts$230%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$244,766 in reported general payments places this provider in the 95th percentile of 1,380 physician assistant providers in Missouri.

See all physician assistant providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab26$106,414
ZoryveRoflumilast23$19,947
Acitretin32$4,320
Clobetasol Propionate114$4,181
Doxycycline Hyclate182$4,098
Betamethasone Dipropionate87$3,833
Tacrolimus37$3,131
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc138$1,868
Ketoconazole97$1,679
Triamcinolone Acetonide90$1,270
ValacyclovirValacyclovir Hcl36$1,013
Fluticasone Propionate43$819
Imiquimod27$788
Clindamycin Phosphate26$730
Pentoxifylline14$694

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Arcutis Biotherapeutics, Inc.Zoryve$1,977$19,94723 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,380 physician assistant providers in Missouri.

Other physician assistant in Lees Summit

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →